Have an Innovative Wound Care Product?

Terms & Conditions

These terms and conditions (“Terms”) govern the iNova Challenge (defined below) and any applications you submit on Coventured (the “Site”) in relation to the iNova Challenge. By participating in the iNova Challenge, you represent and agree to be bound by these Terms. These Terms represent a binding agreement between you and iNova Pharmaceuticals (Singapore) Pte Limited (“iNova Pharmaceuticals”).

1. The iNova Challenge Process

Who can apply? 
If you or your organisation (i) has products, technology or fast R&D solutions in the wound care category which can stretch our relevant brands into adjacent segments and (ii) meet the eligibility and qualification criteria set out either on the Site or separately in writing, then please apply.

By submitting an application to the iNova Challenge, you declare that you are authorised to enter into this competition (“iNova Challenge”). 

The application process
If you believe that your project and/or company fits the strategic priorities identified in the iNova Challenge, you will be asked to complete an application form. The form will ask for information about you, or your company, your team, and how your product may solve the iNova Challenge. You agree to provide accurate and complete information when completing the form and you agree to keep your information up to date.

All applications received on the Site in relation to the iNova Challenge will be routed to and reviewed by iNova Pharmaceuticals only. All applicants will be notified by iNova Pharmaceuticals within 4 weeks of the application deadline and informed as to whether or not their proposal has been short-listed.

Shortlisted applicants
Following the application, shortlisted applicants will attend a boardroom 'iPitch Slam' where the shortlisted applicants will provide a presentation of their proposed solution. Once any winning solution is chosen, you will have a chance to collaborate with iNova Pharmaceuticals following the execution of a binding contract between the Parties.

2. Confidentiality

For the purpose of these Terms and Conditions, Confidential Information means information (in any format) that is disclosed by or on behalf of a Party that belongs to or relates to that Party, and that is (or is reasonably regarded as) the confidential information of that Party, including information that is treated or designated as confidential by that Party or that is not generally known outside that Party. Confidential information may include; technical and operational information, financial data, product know-how, personnel information, contracts, customer and supplier information, business plans, systems information and other commercially sensitive business information. 

You understand and acknowledge that you may disclose certain Confidential Information as part of your application to the iNova Challenge and in return you may receive Confidential Information from iNova Pharmaceuticals. 

Where Confidential Information belongs or relates to a Party or its affiliates, that Party is referred to as the Discloser.

Where a Party receives Confidential Information belonging or relating to the other Party from the Discloser, that Party is referred to as the Recipient.

Use and disclosure
The Recipient must: (i) keep confidential all Confidential Information and, except as permitted under the Terms and Conditions, not use or disclose any of it without the Discloser’s prior consent; (ii) use the Confidential Information solely for the purpose of the iNova Challenge (the “Purpose”); (iii) ensure that the Confidential Information is only disclosed to those of its representatives who need to access the Confidential Information for the Purpose and who are aware of, and obligated to comply with, the Recipient’s obligations under the Terms and Conditions; and (iv) not seek to profit from the Confidential Information other than as explicitly agreed and authorised by the Discloser.

The Recipient’s obligations under the above paragraph do not apply to any Confidential Information which: (i) is in, or comes into, the public domain other than by a breach of the Terms and Conditions or an obligation of confidence owed to the Discloser; (ii) was lawfully in the Recipient’s possession prior to disclosure by or on behalf of the Discloser; (iii) information which is independently developed by or on behalf of the Recipient without use of or reliance upon the Confidential Information of the Discloser; (iv) was received from a third party who is not under an obligation to the Discloser to maintain the Confidential Information in confidence and who legitimately obtained the Confidential Information; or (v) it is required to disclose in order to enforce the Terms and Conditions or under law or a binding order of a governmental agency or court, provided that the Recipient must first: (a) inform the Discloser in writing of the required disclosure in advance to enable the Discloser to have a reasonable opportunity to object to the required disclosure; and (b) use all reasonable efforts to obtain confidential treatment of such Confidential Information that is required to be disclosed.

The Recipient acknowledges that its obligations under this section apply in addition to, and nothing in the Terms and Conditions limits, any common law or equitable obligations of confidence owed to the Discloser by the Recipient.

Both Parties must keep the fact of discussions between the Parties relating to the Purpose, confidential for the duration of the iNova Challenge and for a period of 2 years thereafter. 
Neither Party is permitted to make any disclosure or announcement regarding the Purpose without the prior written consent of the other party.

Security and control
The Recipient must: (i) establish and maintain effective security measures to safeguard Confidential Information of the other Party from disclosure, access or use not authorised by the Terms and Conditions; and (ii) keep Confidential Information under its control.

Duration and return of Confidential Information
The Discloser may, at any time, by written notice to the Recipient, require the Recipient to cease all use of the Discloser’s Confidential Information. Upon receipt of such notice, the Recipient must promptly, at the Discloser’s option: (i) return all copies and records of the Discloser’s Confidential Information to the Discloser; or (ii) permanently delete or destroy all copies or records of the Discloser’s Confidential Information in the Recipient’s possession or control.

Notwithstanding the foregoing, the Recipient (i) may keep a reasonable number of archival copies of the Confidential Information as may be required by the Recipient to comply with any applicable law, and (ii) will not be required to erase Confidential Information that exists only in electronic backed-up form in accordance with the Recipient’s ordinary data back-up practices.

Indemnity
Each Party indemnifies the other Party against all losses damages, expenses and legal costs (on a solicitor and own client basis and whether incurred by or awarded against that other Party) that that other Party may reasonably sustain or incur as a result, whether directly or indirectly, of any breach by the first Party of its obligations under Article 2 of the Terms and Conditions (Confidentiality).

Acknowledgment
Each Party acknowledges and agrees that the disclosure of Confidential Information does not give the Recipient or any other person any right, title or interest in the Confidential Information or in any intellectual property rights of the Discloser.

Except to the extent agreed in definitive transaction documents giving effect to the Purpose, the Recipient acknowledges that the Discloser does not make any representation or warranty, express or implied as to the accuracy or completeness of the Confidential Information or that the Confidential Information is the totality of the information that may be relevant to the Recipient’s consideration of the Purpose.

The Recipient acknowledges that the Discloser has absolute discretion relating to any matter arising in connection with the Purpose, including: (a) whether or not and the extent to which any Confidential Information will be disclosed to the Recipient or any other person;
(b) whether or not and the extent to which the Discloser participates in discussions or negotiations with the Recipient or any other person; and (c) the right at any time to immediately terminate discussions or negotiations with the Recipient without giving reasons and to promote or pursue discussions or negotiations with any other person.

If you submit an idea or suggestion as part of your application, you acknowledge that iNova Pharmaceuticals or a third party acting on its behalf, may have previously worked on or may be working on the same or a similar idea. By submitting your idea, you agree that we may continue to develop the idea (or a similar idea) independently of, and without acknowledging, your idea.

3. Your Obligations

You acknowledge that you shall: (a) comply with all applicable laws and regulations, as well as iNova’s procurement and compliance policies, to the fullest extent when participating in the iNova Challenge; (b) comply with any and all guidelines, notices, operating rules, and policies and instructions pertaining to the iNova Challenge, as well as any amendments thereto issued by iNova from time to time; and (c) provide accurate and up to date information and documents for the purpose of the iNova Challenge.

You shall not be permitted to: 
a)    use the Site or iNova Challenge for any fraudulent or illegal activities or carry out acts which are fraudulent in nature during your participation in the iNova Challenge (for example, fraudulently inflating or falsifying numbers etc.); 
b)    access the iNova Challenge through any computer program other than the Site. Such computer programs include, but are not limited to automated bots and other tools meant to replace or supplement the Site. In addition, scripts and completely or partially automated programs are prohibited, including without limitation, auto-refresh functions and other integrated browser mechanisms that use or concern automated procedures for access to or participation in the iNova Challenge; 
c)    disclose or provide to any third party the Confidential Information without written consent from iNova, and you shall require each of their officers, employees and related persons to comply with the confidentiality obligations herein these Terms; 
d)    create or use cheats, mods and/or hacks, or any other third party software products that may change the result of the iNova Challenge; 
e)    use software that allows the mining or scraping of data or otherwise intercepts or collects information in connection with the iNova Challenge; 
f)    conduct anything which may compromise or interrupt the proper functioning of the Site; 
g)    conduct anything which may allow unauthorised access to data including personal data; or 
h)    sell, buy or trade your accounts, and the foregoing shall include all circumventions, similar actions or actions that produce an effect that matches the aforementioned prohibitions.

You warrant that you own the rights in any information you share with iNova Pharmaceuticals in your application and any information supplied to iNova Pharmaceuticals does not infringe the intellectual property rights, confidentiality or the rights of any third party. You will retain ownership of all protected intellectual property included your application. In the event that your proposal is selected, you will be required to enter into a mutually agreed contract with iNova Pharmaceuticals which will set out the commercial terms of the collaboration, including the rights and obligations relating to the parties' respective intellectual property.

5. Changes to these Terms and Conditions 

You agree that we may change or revise these Terms and Conditions from time to time by updating this posting on the Site, and that such changes will take effect immediately upon our posting, so please check these Terms and Conditions when you visit the Site to keep up to date. Your participation in the application process reaffirms your continuing agreement to the then-current Terms and Conditions.

6. Privacy

iNova Pharmaceuticals takes your privacy very seriously and will use and protect any personal information you provide on this website in accordance with our Privacy Policy. 

7. Disclaimer

To the fullest extent permissible pursuant to applicable law, iNova Pharmaceuticals expressly disclaims all conditions and warranties of any kind, whether express or implied, including, but not limited to all implied warranties of merchantability or fitness for a particular purpose, title and non-infringement. 

You accept that iNova Pharmaceuticals shall not be responsible to you for any loss, damage, fine, regulatory action, claim or compensation of whatever nature arising from or related to the iNova Challenge (collectively, the “Liabilities”), including but not limited to (a) your breach of these Terms; (b) any alleged unauthorised transactions, disruptions, errors, defects or unavailability of the Site or iNova Challenge; or (c) any loss of data or damage to any of your devices, to the fullest extent permitted by law.

In addition to other limitations and exclusions in these Terms, in no event will iNova Pharmaceuticals or its directors, officers, employees, agents or other representatives be liable for any direct, indirect, special, incidental, consequential, or punitive damages, or any other damages of any kind, arising out of or related to the program.  There is no liability, whether in contract, warranty, tort (including negligence) or otherwise. These exclusions and limitations of liability will apply to the fullest extent permitted by law and will survive cancellation or termination of your participation in the iNova Challenge.

8. Severability

If any provision of these Terms shall be found to be unlawful, void, or for any reason unenforceable, then that provision shall be deemed severable from these Terms and shall not affect the validity and enforceability of any remaining provisions.

9. Waiver

No failure on the part of iNova Pharmaceuticals to enforce any part of these Terms shall constitute a waiver of any of iNova Pharmaceuticals' rights under these Terms whether for past or future actions on the part of any person.

10. Applicable Law and Jurisdiction

These Terms and Conditions and any disputes arising under or related to these Terms and Conditions (whether in contract, tort (including negligence), statute or otherwise) will be governed by the laws of Singapore, without reference to its conflicts of law principles. Any legal actions, suits or proceedings arising out of these Terms and Conditions (whether in contract, tort (including negligence), statute or otherwise) will be brought exclusively in Singapore, and you hereby accept and submit to the personal jurisdiction of these courts with respect to any legal actions, suits or proceedings arising out of these Terms and Conditions.

11. Miscellaneous

A person who is not a party to these Terms shall have no right under the Contracts (Rights of Third Parties) 2001 to enforce any of these terms and conditions. These Terms shall be effective from the date that you signify your agreement to these Terms and shall continue to be effective until the end of the iNova Challenge. 

You may terminate your participation in the iNova Challenge by notifying us in writing. 
iNova Pharmaceuticals reserves the right to terminate the iNova Challenge or any part of these Terms at any time without providing reason. 

iNova Pharmaceticals’ decision on all matters relating to or in connection with the iNova Challenge shall be final, binding and conclusive on all participants, including but not limited to any decision on the eligibility and qualification of any participant, or to cancel or suspend the iNova Challenge, and no correspondence or disputes will be entertained.

You acknowledge and agree that any records (including records of any telephone conversations relating to the iNova Challenge, if any) maintained by iNova Pharmaceuticals and iNova Pharmaceuticals’ service providers relating to or in connection with the iNova Challenge shall be binding on you and conclusive for all purposes whatsoever and shall be conclusive evidence of any information and data transmitted between iNova Pharmaceuticals and you. You hereby agree that all such records are admissible in evidence and you shall not challenge or dispute the admissibility, reliability, accuracy or the authenticity of such records merely on the basis that such records are in electronic form or are the output of a computer system, and you hereby waive any of your rights, if any, to so object.